Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Vincristine × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Follicular 8 Lymphoma, Large B-Cell, Diffuse 7 Sarcoma, Ewing 5 Rhabdomyosarcoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 4 Lymphoma 4 Leukemia, Biphenotypic, Acute 4 Sarcoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Wilms Tumor 2 Rhabdomyosarcoma, Embryonal 2 Recurrence 2 Osteosarcoma 2 Neuroblastoma 2 Desmoplastic Small Round Cell Tumor 2 Waldenstrom Macroglobulinemia 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1 Pleuropulmonary blastoma 1 Plasmablastic Lymphoma 1 PRETEXT I Hepatoblastoma 1 Neurofibromatosis 1 1

Interventions

poly ICLC 1 pembrolizumab 1 atezolizumab 1 Specimen Handling 1 Sorafenib 1 Nivolumab 1 Irinotecan 1 Ipilimumab 1 DT2216 1 Cyclophosphamide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡